Clinical Trial Update: Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating pregabalin versus placebo for neuropathic pain in diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Diabetic Peripheral Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Diabetic Neuropathies | Phase 3 | Status: COMPLETED